02659.HK
Shanghai Bao Pharmaceuticals Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 16.06
−2.25%Aug 28, 2026, 10:10 UTC
Shanghai Baoye Pharmaceutical reported interim results for the six months ended June 2026, with revenue down 76.5% year-on-year to RMB 9.875 million and a narrowed net loss of RMB 154 million.
Source: